VEGFA and neoplasm: Additionally, emerging prognostic biomarkers such as vascular endothelial growth factor (VEGF), prostasin (PSN), transferrin, and bikunin have shown promise in predicting tumor progression and treatment outcomes [13, 14, 15, 16, 17, 18].